DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 03 · Volume 28 · 2002 DOI: 10.1055/s-002-2043 Recombinant Factor VIII Products and Hemophilia A: Efficacy, Safety, and Inhibitor Development Editor in Chief Eberhard F. Mammen M.D.,, Guest Editor Jan J. Michiels M.D. Ph.D.

Brinkhous, Kenneth; Sandberg, Helena; Widlund, Lars; Read, Marjorie; Nichols, Timothy; Sigman, Jeffery; Oswaldsson, Ulla; Schaub, Robert G.; Mikaelsson, Marianne: Preclinical Pharmacology of Albumin-Free B-Domain Deleted Recombinant Factor VIII
Kreuz, Wolfhart; Ettingshausen, Carmen Escuriola; Zyschka, Alex; Oldenburg, Johannes; Saguer, Inmaculada Martinez; Ehrenforth, Silke; Klingebiel, Thomas: Inhibitor Development in Previously Untreated Patients with Hemophilia A: A Prospective Long-Term Follow-Up Comparing Plasma-Derived and Recombinant Products
Klinge, Jens; Ananyeva, Natalya M.; Hauser, Charlotte A. E.; Saenko, Evgueni L.: Hemophilia A-From Basic Science to Clinical Practice